Skip to main content

Advertisement

Log in

Reperfusion strategies in stroke with medium-to-distal vessel occlusion: a prospective observational study

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Introduction

Medium vessel occlusion (MeVO) accounts for 30% of acute ischemic stroke cases. The risk/benefit profile of endovascular thrombectomy (EVT) and intravenous thrombolysis (IVT) or the combination of the two (bridging therapy (BT)) is still unclear in MeVO. Here, we compare reperfusion strategies in MeVO for clinical and radiological outcomes.

Methods

This prospective single center study enrolled consecutive patients with AIS due to primary MeVO undergoing IVT, EVT, or BT at a comprehensive stroke center. Primary outcome was good functional status, defined as modified Rankin Scale (mRS) 0–2 at 3-month follow-up. Additional outcomes included mortality, successful recanalization, defined as mTICI ≥ 2b, stroke severity at discharge, and symptomatic intracerebral hemorrhage (sICH) according to SITS-MOST criteria. Logistic regression was modeled to define independent predictors of the primary outcome.

Results

Overall, 180 consecutive people were enrolled (IVT = 59, EVT = 38, BT = 83), mean age 75. BT emerged as independent predictor of primary outcome (OR = 2.76, 95% CI = 1.08–7.07) together with age (OR = 0.94, 95% CI = 0.9–0.97) and baseline NIHSS (OR = 0.88, 95% CI = 0.81–0.95). BT associated with a 20% relative increase in successful recanalization compared to EVT (74.4 vs 56.4%, p = 0.049). Rates of sICH (1.1%) and procedural complications (vasospasm 4.1%, SAH in 1.7%) were very low, with no difference across groups.

Discussion

BT may carry a higher chance of good functional outcome compared to EVT/IVT only in people with AIS due to MeVO, with marginally higher rates of successful recanalization. Randomized trials are needed to define optimal treatment tailoring for MeVO.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Saver JL, Chapot R, Agid R, Hassan A, Jadhav AP, Liebeskind DS, Lobotesis K, Meila D, Meyer L, Raphaeli G, Gupta R (2020) Distal thrombectomy summit group*†. Thrombectomy for distal, medium vessel occlusions: a consensus statement on present knowledge and promising directions. Stroke 51(9):2872–2884

  2. Ospel JM, Menon BK, Demchuk AM, Almekhlafi MA, Kashani N, Mayank A, Fainardi E, Rubiera M, Khaw A, Shankar JJ, Dowlatshahi D, Puig J, Sohn SI, Ahn SH, Poppe A, Calleja A, Hill MD, Goyal M (2020) Clinical course of acute ischemic stroke due to medium vessel occlusion with and without intravenous alteplase treatment. Stroke 51(11):3232–3240

  3. Vidale S, Romoli M, Agostoni EC (2021) Endovascular treatment versus intravenous thrombolysis alone in isolated M2 occlusion: a meta-analysis. Neurol Sci 42:4221–4224

    Article  PubMed  Google Scholar 

  4. Goyal M, Menon BK, Van Zwam WH, Dippel DWJ, Mitchell PJ, Demchuk AM, Dávalos A, Majoie CBLM, Van Der Lugt A, De Miquel MA et al (2016) Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 387:1723–1731

    Article  PubMed  Google Scholar 

  5. Jovin TG, Nogueira RG, Lansberg MG, Demchuk AM, Martins SO, Mocco J, Ribo M, Jadhav AP, Ortega-Gutierrez S, Hill MD et al (2022) Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): a systematic review and individual patient data meta-analysis. Lancet 399:249–258

    Article  PubMed  Google Scholar 

  6. Nogueira RG, Mohammaden MH, Haussen DC, Budzik RF, Gupta R, Krajina A, English JD, Malek AR, Sarraj A, Narata AP, Taqi MA, Frankel MR, Miller TR, Grobelny T, Baxter BW, Bartolini BM, Jenkins P, Estrade L, Liebeskind D, Veznedaroglu E, Trevo Registry Investigators (2021) Endovascular therapy in the distal neurovascular territory: results of a large prospective registry. J Neurointerv Surg 13(11):979–984

  7. Goyal M, Ospel JM, Menon BK, Hill MD (2020) MeVO: the next frontier? J Neurointerv Surg 12(6):545–547

  8. Menon BK, Hill MD, Davalos A, Roos YBWEM, Campbell BCV, Dippel DWJ, Guillemin F, Saver JL, Van Der Lugt A, Demchuk AM et al (2019) Efficacy of endovascular thrombectomy in patients with M2 segment middle cerebral artery occlusions: meta-analysis of data from the HERMES collaboration. J Neurointerv Surg 11:1065–1069

    Article  PubMed  Google Scholar 

  9. Gory B, Lapergue B, Blanc R, Labreuche J, Ben Machaa M, Duhamel A, Marnat G, Saleme S, Costalat V, Bracard S et al (2018) Contact aspiration versus stent retriever in patients with acute ischemic stroke with M2 occlusion in the aster randomized trial (contact aspiration versus stent retriever for successful revascularization). Stroke 49:461–464

    Article  PubMed  Google Scholar 

  10. Grossberg JA, Rebello LC, Haussen DC, Bouslama M, Bowen M, Barreira CM, Belagaje SR, Frankel MR, Nogueira RG (2018) Beyond large vessel occlusion strokes: distal occlusion thrombectomy. Stroke 49:1662–1668

    Article  PubMed  Google Scholar 

  11. Ospel JM, Goyal M (2021) A review of endovascular treatment for medium vessel occlusion stroke. J Neurointerv Surg 13:623–630

    Article  PubMed  Google Scholar 

  12. Berge E, Whiteley W, Audebert H, De Marchis GM, Fonseca AC, Padiglioni C, de la Ossa NP, Strbian D, Tsivgoulis G, Turc G (2021) European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J 6(1):I–LXII

  13. Crockett MT, Phillips TJ, Chiu AHY (2019) Dual suction Headway27 microcatheter thrombectomy for the treatment of distal intracranial arterial occlusion strokes: initial experience with the micro-ADAPT technique. J Neurointerv Surg 11:714–718

    Article  PubMed  Google Scholar 

  14. Von Kummer R, Broderick JP, Campbell BCV, Demchuk A, Goyal M, Hill MD, Treurniet KM, Majoie CBLM, Marquering HA, Mazya MV et al (2015) The heidelberg bleeding classification: classification of bleeding events after ischemic stroke and reperfusion therapy. Stroke 46:2981–2986

    Article  Google Scholar 

  15. Menon BK, Al-Ajlan FS, Najm M, Puig J, Castellanos M, Dowlatshahi D, Calleja A, Il SS, Ahn SH, Poppe A et al (2018) Association of clinical, imaging, and thrombus characteristics with recanalization of visible intracranial occlusion in patients with acute ischemic stroke. JAMA - J Am Med Assoc 320:1017–1026

    Article  Google Scholar 

  16. Menon BK, D’Esterre CD, Qazi EM, Almekhlafi M, Hahn L, Demchuk AM, Goyal M (2015) Multiphase CT angiography: a new tool for the imaging triage of patients with acute ischemic stroke. Radiology 275:510–520

    Article  PubMed  Google Scholar 

  17. Saber H, Narayanan S, Palla M, Saver JL, Nogueira RG, Yoo AJ, Sheth SA (2018) Mechanical thrombectomy for acute ischemic stroke with occlusion of the M2 segment of the middle cerebral artery: a meta-analysis. J Neurointerv Surg 10:620–624

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

FR: study design, data collection, and manuscript drafting. MR: study design, manuscript drafting, and statistical analysis. MP, GL, and AZ: study design supervision, and revised manuscript for intellectual content. MG, SF, LP, FN, MP, SG, FT, CP, and LM: revised manuscript for intellectual content.

Corresponding author

Correspondence to Andrea Zini.

Ethics declarations

Ethical approval

Ethical approval was not sought for the present study because the study was nested within the local stroke registry.

Competing interests

The authors declare no competing interests. Relevant disclosures outside the submitted work: AZ declares consulting fees from Boehringer-Ingelheim, Alexion, and CLS Behring and declares grant from the Italian Ministry of Health as principal investigator for clinical trial (RF-2019–12370834). DT reports fees for advisory board and speaker honoraria from Abbott, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Medtronic, and Pfizer.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 53 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rizzo, F., Romoli, M., Simonetti, L. et al. Reperfusion strategies in stroke with medium-to-distal vessel occlusion: a prospective observational study. Neurol Sci 45, 1129–1134 (2024). https://doi.org/10.1007/s10072-023-07089-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-023-07089-w

Keywords

Navigation